Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

Learn about the latest promising breakthroughs in immunotherapy, the challenges facing their widespread use, and what your cancer team needs to know about the future of cancer treatment.
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care communi- ty. Founded in 1974, ACCC is a powerful network of 25,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve—so has ACCC—adapt- …
Envision a day that cancer clinicians can ask an app to advise on immuno-oncology (IO) treatment options for a patient. That day may not be far off.
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 28,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve—so has ACCC—adapting …
Envision a day that cancer clinicians can ask an app to advise on immuno-oncology (IO) treatment options for a patient. That day may not be far off. Big data, deep analytics, and predictive modeling methods are transforming how cancer clinicians weigh treatment options.
The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 28,000 multidisciplinary practitioners from 2,100 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve—so has ACCC—adapting …
SARS-CoV-2 and the resulting respiratory tract infection COVID-19 has upended our society and forcefully changed the way we care for patients. Since the emergence of the virus in early 2020, there have been questions surrounding the risk posed to patients with a cancer diagnosis and the safety of anticancer therapies.
November 20, 2020
If your cancer center is ready to begin or expand its journey to value-based care—but you are not sure how to get started—these modules can help.
November 20, 2020
This two-part series includes webinars developed in conjunction with the multidisciplinary care team who have deep expertise in caring for patients with cSCC as well as high-risk non-melanoma skin cancers.
2023 – 2024 Olalekan Ajayi, PharmD, MBA (Re)Building the Oncology Workforce to Deliver Next Generation Cancer Care 2022 – 2023 David R. Penberthy, MD, MBA Leveraging Technology to Transform Cancer Care Delivery and the Patient Experience 2021 – 2022 Krista Nelson, MSW, LCSW, OSW-C, FAOSW Real-World Lessons from COVID-19: Driving Oncology Care Forward 2020 – 2021 Randall A. Oyer, MD Community …
Integrating pharmacists into oncology care delivery models has shown to improve outcomes1 for patients and boost the financial stability of cancer programs and practices. But billing for pharmacy services can be onerous and complicated. In the latest installment of an ACCC webinar series marking American Pharmacists Month, experts discussed how to bill for pharmacists' services in chemotherapy management …
November 19, 2020
Join your colleagues in one of several regional roundtables to connect with like-minded financial advocates in your area and address topics of mutual interest. The Financial Advocacy Town Network Town Hall: Regional Roundtables is in collaboration with the Oncology State Societies at ACCC as part of the State Society Education Series. Register for the Webinar Series For the best registration and viewing …
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PHESGO safely and effectively. See full prescribing information for PHESGO. PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection, for subcutaneous use Initial U.S. Approval: 2020 WARNING: CARDIOMYOPATHY, EMBRYO-FETAL TOXICITY, and …
November 17, 2020
Francinna Scott-Jones, Financial Coordinator, Northside Hospital Dan Sherman, MA, LPC, The NaVectis Group Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance Financial advocates who serve radiation oncology departments require specific knowledge and skills to help patients avoid financial toxicity. Expert panelists will discuss the unique financial concerns for radiation oncology …
Microsoft Word - ACCC - RO Model Final Rule Letter from Dr. Oyer.docx EXECUTIVE OFFICE: 1801 Research Boulevard • Suite 400 • Rockville, MD 20850-3184 • Phone: 301.984.9496 • Fax: 301.770.1949 www.accc-cancer.org OFFICERS President Randall A. Oyer, MD Ann B. Barshinger Cancer Institute Lancaster, Pennsylvania President-Elect Krista …
We take a look at how the COVID-19 pandemic has impacted lung screenings across the country and how oncology teams are adapting their outreach and education to reach as many people as possible.
Webinars How to Onboard APPs Into Your Practice Presented by: Todd Pickard, MMSc, PA-C, DFAAPA, FASCO, American Society of Clinical Oncology November 15, 2022 VIEW ON-DEMAND RECORDING The Financial Toxicity of Cancer Care: What It Is, How to Manage It as Providers, and How to Mitigate It Presented by: Jason Astrin, DMSc, MBA, PA-C, DFAAPA, US Oncology Network November 4, 2022 VIEW ON-DEMAND …
NO PURCHASE NECESSARY. OPEN ONLY TO LEGAL RESIDENTS OF THE UNITED STATES OF AMERICA WHO ARE AT LEAST 18 YEARS OLD AT TIME OF ENTRY. Void where prohibited by law. This sweepstakes begins on February 1, 2024 at 12:01 a.m. ET and ends on February 8, 2024 at 5:00 p.m. ET (“Promotion Period”). Sponsor’s computer is the official time keeping device for this Sweepstakes. Enter the Sweepstakes during the …
NCOA Annual Achievement Award About the Award The North Carolina Oncology Association (NCOA) is thrilled to announce its Annual Achievement Award. This award is presented annually to an NCOA member in recognition of their exceptional leadership, service, passion for oncology, and contributions to the success of the Association through their actions and dedication. Winners will be awarded at the …
NO PURCHASE NECESSARY. OPEN ONLY TO LEGAL RESIDENTS OF THE UNITED STATES OF AMERICA WHO ARE AT LEAST 18 YEARS OLD AT TIME OF ENTRY. Void where prohibited by law. This sweepstakes begins on February 1, 2024 at 12:01 a.m. ET and ends on February 9, 2024 at 5:00 p.m. ET (“Promotion Period”). Sponsor’s computer is the official time keeping device for this Sweepstakes. Enter the Sweepstakes during the …